Table 3.
Luminex multiplex panel data
| Ligand Mean Value (SD) | Survived | Died | P Value |
|---|---|---|---|
| n = 26 | n = 15 | ||
| CD40 Ligand, pg/mL | 761.10 (882.98) | 391.10 (335.67) | 0.15 |
| EGF, pg/mL | 26.16 (26.70) | 8.60 (7.50) | 0.02* |
| Eotaxin, pg/mL | 84.71 (38.72) | 79.10 (48.14) | 0.70 |
| FGF basic, pg/mL | 7.07 (12.09) | 10.75 (12.18) | 0.37 |
| Flt-3 ligand, pg/mL | 53.64 (52.35) | 57.75 (20.79) | 0.78 |
| Fractalkine, pg/mL | 573.20 (229.58) | 719.80 (287.87) | 0.10 |
| G-CSF, pg/mL | 18.36 (12.79) | 12.78 (722.96) | 0.18 |
| GM-CSF, pg/mL | 118.30 (102.83) | 149.80 (82.01) | 0.34 |
| Granzyme B, pg/mL | 14.90 (9.58) | 14.56 (10.81) | 0.92 |
| GROa, pg/mL | 60.22 (24.30) | 87.42 (108.18) | 0.25 |
| GROb, pg/mL | 336.00 (196.92) | 267.20 (154.30) | 0.28 |
| IFN-a, pg/mL | 4.78 (4.21) | 5.58 (9.92) | 0.73 |
| IFN-B, pg/mL | 0.96 (0.54) | 0.56 (1.24) | 0.26 |
| IFN-y, pg/mL | 4.90 (5.68) | 4.13 (4.68) | 0.67 |
| IL-1a, pg/mL | 8.42 (4.79) | 5.08 (2.84) | 0.03* |
| IL-1B, pg/mL | 1.66 (0.79) | 1.47 (0.40) | 0.43 |
| IL-1ra, pg/mL | 1616.00 (1255.74) | 5801.00 (6030.25) | 0.001** |
| IL-2, pg/mL | 1.72 (2.03) | 0.89 (1.27) | 0.19 |
| IL-3, pg/mL | 10.38 (11.08) | 11.06 (10.87) | 0.86 |
| IL-4, pg/mL | 0.87 (0.98) | 0.41 (0.29) | 0.10 |
| IL-5, pg/mL | 4.71 (1.19) | 3.86 (0.79) | 0.03* |
| IL-6, pg/mL | 697.80 (2297.27) | 1231.00 (2807.93) | 0.53 |
| IL-7, pg/mL | 3.49 (2.21) | 2.70 (1.62) | 0.26 |
| IL-8, pg/mL | 7.30 (4.69) | 13.87 (9.61) | 0.01* |
| IL-10, pg/mL | 232.70 (161.94) | 278.80 (162.29) | 0.41 |
| IL-12 p70, pg/mL | 2.20 (2.30) | 1.72 (1.94) | 0.53 |
| IL-13, pg/mL | 42.69 (18.22) | 31.22 (14.33) | 0.06 |
| IL-15, pg/mL | 3.70 (1.84) | 4.33 (1.85) | 0.32 |
| IL-17A, pg/mL | 2.03 (1.92) | 1.80 (2.14) | 0.75 |
| IL-17E, pg/mL | 27.76 (44.65) | 7.56 (10.01) | 0.11 |
| IL-33, pg/mL | 9.18 (4.84) | 6.63 (2.35) | 0.08 |
| IP-10, pg/mL | 790.60 (900.84) | 1168.00 (992.29) | 0.24 |
| MCP-1, pg/mL | 281.40 (301.84) | 357.50 (218.36) | 0.42 |
| MIP-1a, pg/mL | 9.28 (4.61) | 10.82 (6.84) | 0.42 |
| MIP-1B, pg/mL | 158.20 (56.29) | 129.80 (48.19) | 0.13 |
| MIP-3a, pg/mL | 54.48 (74.26) | 65.01 (191.42) | 0.64 |
| MIP-3B, pg/mL | 152.90 (91.82) | 226.00 (122.35) | 0.04* |
| PDGF-AA, pg/mL | 1729.00 (1389.01) | 959.80 (861.68) | 0.07 |
| PDGF-AB/BB, pg/mL | 610.30 (635.42) | 273.10 (216.61) | 0.07 |
| PD-L1/B7-H1, pg/mL | 841.30 (3516.13) | 171.80 (123.95) | 0.49 |
| RANTES, pg/mL | 27005.00 (23226.68) | 12112.00 (10793.81) | 0.03* |
| TGF-a, pg/mL | 7.31 (5.79) | 4.10 (3.51) | 0.07 |
| TNF-a, pg/mL | 13.76 (11.97) | 21.15 (23.51) | 0.12 |
| TRAIL, pg/mL | 10.32 (7.71) | 13.54 (14.58) | 0.38 |
| VEGF, pg/mL | 202.40 (150.49) | 308.30 (201.76) | 0.08 |
IL-1ra, IL1 receptor antagonist. Significant P values are indicated in bold and italic font.